As identified in 18F-dopa PET, the greatest regional decrease in VMAT2 binding in PD (using 18F-AV-133) was observed in the posterior putamen, followed by the anterior putamen and caudate nucleus (215). This evidence concerns the gene SLC18A2 and Parkinson disease.